ELP1 and medulloblastoma: However, as all but one of the cases was in the MBSHH subtype and the frequency in non SHH pathway medulloblastoma for ELP1 was only 1/542 (0.18%), similar to the 0.1% frequency in controls, we have assumed that all of the risk related to the MBSHH subtype.